These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11155742)

  • 21. Relationship of HLA and platelet-reactive antibodies in alloimmunized patients refractory to platelet therapy.
    Brubaker DB; Romine M
    Am J Hematol; 1987 Dec; 26(4):341-52. PubMed ID: 3687931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disappearance of HLA and platelet-specific antibodies in acute leukaemia patients alloimmunized by multiple transfusions.
    Murphy MF; Metcalfe P; Ord J; Lister TA; Waters AH
    Br J Haematol; 1987 Nov; 67(3):255-60. PubMed ID: 3689693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of platelet specific antibody (anti-Sib(a)).
    Liu D; Lu P; Wang J; Bao Y
    Chin Med J (Engl); 1996 Aug; 109(8):615-7. PubMed ID: 9206062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-specific antibodies in HLA-immunized patients receiving chronic platelet support.
    Sanz C; Freire C; Alcorta I; Ordinas A; Pereira A
    Transfusion; 2001 Jun; 41(6):762-5. PubMed ID: 11399816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection and identification of platelet-associated alloantibodies by a solid-phase modified antigen capture enzyme-linked immunosorbent assay method and its correlation to platelet refractoriness in multiplatelet concentrate-transfused patients.
    Jain N; Sarkar S; Philip J
    Immunohematology; 2014; 30(3):123-5. PubMed ID: 25695438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
    Amemiya Y
    Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-reactive HLA antibodies associated with low posttransfusion platelet increments:a comparison between the monoclonal antibody-specific immobilization of platelet antigens assay and the lymphocytotoxicity test.
    Kurz M; Knöbl P; Kalhs P; Greinix HT; Höcker P; Panzer S
    Transfusion; 2001 Jun; 41(6):771-4. PubMed ID: 11399818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alloimmunization to platelet-specific antigens on glycoproteins IIb-IIIa and Ib/IX in multiply transfused thrombocytopenic patients.
    Kickler T; Kennedy SD; Braine HG
    Transfusion; 1990 Sep; 30(7):622-5. PubMed ID: 2402776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease.
    Nickel RS; Horan JT; Abraham A; Qayed M; Haight A; Ngwube A; Liang H; Luban NLC; Hendrickson JE
    Br J Haematol; 2020 Apr; 189(1):162-170. PubMed ID: 31674662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA antibodies in multiple transfused patients.
    Lam CP; Chow MP
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Dec; 50(6):439-42. PubMed ID: 1338018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice.
    Poston JN; Jash A; Hannan LM; Hay AM; Usaneerungrueng C; Howie HL; Kapp LM; Zimring JC
    Transfusion; 2021 Mar; 61(3):687-691. PubMed ID: 33336414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of HLA antibodies in transfused patients with and without red cell antibodies.
    Buetens O; Shirey RS; Goble-Lee M; Houp J; Zachary A; King KE; Ness PM
    Transfusion; 2006 May; 46(5):754-6. PubMed ID: 16686842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet transfusion refractoriness caused by a mismatch in HLA-C antigens.
    Saito S; Ota S; Seshimo H; Yamazaki Y; Nomura S; Ito T; Miki J; Ota M; Fukushima H; Maeda H
    Transfusion; 2002 Mar; 42(3):302-8. PubMed ID: 11961234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet alloimmunization after multiple transfusions: a prospective study of 50 patients.
    Godeau B; Fromont P; Seror T; Duedari N; Bierling P
    Br J Haematol; 1992 Jul; 81(3):395-400. PubMed ID: 1390213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unappreciated HLA antibodies in adult immune thrombocytopenic purpura.
    Lin JS; Lyou JY; Chen YJ; Chen PS; Liu HM; Ho CH; Hao TC; Tzeng CH
    J Formos Med Assoc; 2007 Feb; 106(2):105-9. PubMed ID: 17339153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of 4 crossmatching methods for predicting the success of platelet transfusion].
    Santoso S; Kiefel V; Kühn J; Mueller-Eckhardt G; Mueller-Eckhardt C
    Beitr Infusionsther; 1990; 26():153-6. PubMed ID: 1703818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limits of the MAIPA assay when differentiating high-titered platelet-reactive antibodies.
    Agildere A; Wernet D; Schnaidt M
    Beitr Infusionsther Transfusionsmed; 1997; 34():190-3. PubMed ID: 9356673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of the Platelet Refractory Patient.
    Forest SK; Hod EA
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):665-77. PubMed ID: 27113003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D+ platelet transfusions in D- patients: cause for concern?
    Bartley AN; Carpenter JB; Berg MP
    Immunohematology; 2009; 25(1):5-8. PubMed ID: 19856725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pan-reactive platelet antibodies in post-transfusion purpura.
    Taaning E; Tønnesen F
    Vox Sang; 1999; 76(2):120-3. PubMed ID: 10085529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.